The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Vaughn James J since 2015.
The trader's CIK number is 1649689.
At the time of the last reporting, Vaughn James J was the Chief Commercial Officer of Genomic Health Inc. (stock ticker symbol GHDX).
Also see all insider trading activities at Genomic Health Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | GHDX | 0 | $0 | 45,989 | $2,968,129 | 42,417 | $1,330,220 |
| 2018 | GHDX | 0 | $0 | 153,915 | $8,152,565 | 138,937 | $3,715,457 |
| 2017 | GHDX | 0 | $0 | 14,996 | $472,559 | 11,331 | $235,235 |
| 2016 | GHDX | 0 | $0 | 11,997 | $354,448 | 5,997 | $113,283 |
| 2015 | GHDX | 0 | $0 | 2,000 | $58,668 | 2,000 | $37,780 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-10-08 | GHDX | Option Ex | 4,500 | 33.21 | 149,445 |
| 2019-10-08 | GHDX | Sale | 4,500 | 67.75 | 304,875 |
| 2019-09-09 | GHDX | Option Ex | 4,500 | 32.16 | 144,742 |
| 2019-09-09 | GHDX | Sale | 4,500 | 73.15 | 329,170 |
| 2019-08-08 | GHDX | Sale | 4,500 | 73.67 | 331,515 |
| 2019-08-08 | GHDX | Option Ex | 4,500 | 31.82 | 143,176 |
| 2019-07-08 | GHDX | Sale | 4,500 | 57.37 | 258,178 |
| 2019-07-08 | GHDX | Option Ex | 4,500 | 31.12 | 140,040 |
| 2019-06-06 | GHDX | Option Ex | 4,500 | 31.12 | 140,040 |
| 2019-06-06 | GHDX | Sale | 8,745 | 53.36 | 466,641 |
| 2019-05-08 | GHDX | Option Ex | 4,500 | 31.12 | 140,040 |
| 2019-05-08 | GHDX | Sale | 7,244 | 57.95 | 419,775 |
| 2019-04-08 | GHDX | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-04-08 | GHDX | Sale | 3,000 | 67.58 | 202,745 |
| 2019-03-07 | GHDX | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-03-07 | GHDX | Sale | 3,000 | 73.92 | 221,751 |
| 2019-02-19 | GHDX | Option Ex | 1,195 | 29.06 | 34,726 |
| 2019-02-07 | GHDX | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-02-07 | GHDX | Sale | 3,000 | 77.56 | 232,683 |
| 2019-01-17 | GHDX | Option Ex | 2,222 | 29.06 | 64,571 |
| 2019-01-08 | GHDX | Option Ex | 3,000 | 31.12 | 93,360 |
| 2019-01-08 | GHDX | Sale | 3,000 | 66.93 | 200,796 |
| 2018-12-06 | GHDX | Option Ex | 3,000 | 31.12 | 93,360 |
| 2018-12-06 | GHDX | Sale | 3,000 | 74.92 | 224,766 |
| 2018-11-08 | GHDX | Option Ex | 3,000 | 31.12 | 93,360 |
| 2018-11-08 | GHDX | Sale | 3,000 | 86.01 | 258,024 |
| 2018-10-08 | GHDX | Option Ex | 25,000 | 29.25 | 731,325 |
| 2018-10-09 | GHDX | Option Ex | 25,000 | 28.53 | 713,325 |
| 2018-10-08 | GHDX | Sale | 25,000 | 65.77 | 1,644,250 |
| 2018-10-09 | GHDX | Sale | 25,000 | 64.54 | 1,613,575 |
| 2018-06-04 | GHDX | Sale | 93,414 | 45.61 | 4,260,892 |
| 2018-06-04 | GHDX | Option Ex | 80,768 | 25.34 | 2,046,499 |
| 2018-05-02 | GHDX | Sale | 1,497 | 32.50 | 48,652 |
| 2018-01-02 | GHDX | Option Ex | 2,169 | 17.33 | 37,588 |
| 2018-01-02 | GHDX | Sale | 3,004 | 34.09 | 102,406 |
| 2017-11-02 | GHDX | Sale | 1,379 | 32.51 | 44,824 |
| 2017-11-01 | GHDX | Sale | 5,617 | 32.58 | 183,007 |
| 2017-11-02 | GHDX | Option Ex | 924 | 17.33 | 16,012 |
| 2017-11-01 | GHDX | Option Ex | 3,907 | 17.33 | 67,708 |
| 2017-08-08 | GHDX | Option Ex | 6,500 | 23.31 | 151,515 |
| 2017-08-08 | GHDX | Sale | 8,000 | 30.59 | 244,728 |
| 2016-10-06 | GHDX | Sale | 3,000 | 29.68 | 89,043 |
| 2016-08-08 | GHDX | Sale | 3,000 | 28.74 | 86,223 |
| 2016-06-06 | GHDX | Option Ex | 1,997 | 18.89 | 37,723 |
| 2016-06-06 | GHDX | Sale | 1,997 | 28.00 | 55,916 |
| 2016-05-09 | GHDX | Sale | 2,000 | 28.00 | 56,000 |
| 2016-05-09 | GHDX | Option Ex | 2,000 | 18.89 | 37,780 |
| 2016-01-07 | GHDX | Option Ex | 2,000 | 18.89 | 37,780 |
| 2016-01-07 | GHDX | Sale | 2,000 | 33.63 | 67,266 |
| 2015-12-07 | GHDX | Option Ex | 2,000 | 18.89 | 37,780 |
| 2015-12-07 | GHDX | Sale | 2,000 | 29.33 | 58,668 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vaughn James J (Chief Commercial Officer of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.